Back to MACQUARIE GROUP LTD MACQUARIE GROUP LTD

IOVAIOVA

Showing 4 of 24 quarters

Position history for MACQUARIE GROUP LTDMACQUARIE GROUP LTD's holdings in IOVANCE BIOTHERAPEUTICS INC

No. Macquarie Group exited its IOVA (Iovance Biotherapeutics) position in Q2 2025. Its Q1 2025 13F listed 4,791,235 shares worth $16M. Macquarie Group first reported IOVA in Q1 2019 and held it in 21 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$30M

Total Shares Change

-3.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$1.72
0
2025-Q1
Increased
4.8M
+0.8%
$16M0.0%$3.33
28
2024-Q4
Increased
4.8M
+48.9%
$35.2M0.0%$7.40
40
2024-Q3
New
3.2M
—
$30M0.0%$9.39
40

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used